Researchers found that adherence to the first and second annual screenings was 61% and 51%, respectively, with higher lung ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

European Commission President Ursula von der Leyen has revealed an 800-billion-euro defence plan to strengthen Europe's military capabilities. The 'ReArm Europe Plan' aims to increase national ...

Macron sought to warn Trump of appearing weak by rushing into a peace agrement with Putin. European allies have offered peacekeepers to guarantee Ukraine's security after a peace agreement – but ...

For further information, please visit our website www.mestagtherapeutics.com. PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Debate is building over just how deep the Trump administration’s antagonism runs, and whether the real goal is to destroy the European Union. By Steven Erlanger Steven Erlanger, the chief ...

Arm 1 will administer Libtayo on day 5. The Company plans to ... MAIA expects to conduct the trials in the U.S. and select countries in Europe and Asia. MAIA recently announced an amended clinical ...

Welcome back to the China In Eurasia briefing, an RFE/RL newsletter tracking China's resurgent influence from Eastern Europe to Central Asia. I'm RFE/RL's China Global Affairs Correspondent Reid ...